357 related articles for article (PubMed ID: 17709319)
1. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
[TBL] [Abstract][Full Text] [Related]
2. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.
Urosevic M; Conrad C; Kamarashev J; Asagoe K; Cozzio A; Burg G; Dummer R
Hum Pathol; 2005 Sep; 36(9):1020-4. PubMed ID: 16153467
[TBL] [Abstract][Full Text] [Related]
3. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms.
Jaye DL; Geigerman CM; Herling M; Eastburn K; Waller EK; Jones D
Mod Pathol; 2006 Dec; 19(12):1555-62. PubMed ID: 16998465
[TBL] [Abstract][Full Text] [Related]
4. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA
Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
[TBL] [Abstract][Full Text] [Related]
5. CD1c+ and CD303+ dendritic cells in peripheral blood, lymph nodes and tumor tissue of patients with non-small cell lung cancer.
Tabarkiewicz J; Rybojad P; Jablonka A; Rolinski J
Oncol Rep; 2008 Jan; 19(1):237-43. PubMed ID: 18097601
[TBL] [Abstract][Full Text] [Related]
6. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review.
Petrella T; Bagot M; Willemze R; Beylot-Barry M; Vergier B; Delaunay M; Meijer CJ; Courville P; Joly P; Grange F; De Muret A; Machet L; Dompmartin A; Bosq J; Durlach A; Bernard P; Dalac S; Dechelotte P; D'Incan M; Wechsler J; Teitell MA
Am J Clin Pathol; 2005 May; 123(5):662-75. PubMed ID: 15981806
[TBL] [Abstract][Full Text] [Related]
7. CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: description of three cases.
Ascani S; Massone C; Ferrara G; Rongioletti F; Papini M; Pileri S; Cerroni L
J Cutan Pathol; 2008 Oct; 35(10):911-5. PubMed ID: 18494823
[TBL] [Abstract][Full Text] [Related]
8. Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease): lesional cells exhibit an immature dendritic cell phenotype.
Pilichowska ME; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2009 Feb; 131(2):174-82. PubMed ID: 19141377
[TBL] [Abstract][Full Text] [Related]
9. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.
Herling M; Jones D
Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829
[TBL] [Abstract][Full Text] [Related]
10. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.
Garnache-Ottou F; Feuillard J; Ferrand C; Biichle S; Trimoreau F; Seilles E; Salaun V; Garand R; Lepelley P; Maynadié M; Kuhlein E; Deconinck E; Daliphard S; Chaperot L; Beseggio L; Foisseaud V; Macintyre E; Bene MC; Saas P; Jacob MC;
Br J Haematol; 2009 Jun; 145(5):624-36. PubMed ID: 19388928
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous CD4+ CD56+ hematologic malignancies.
Magro CM; Porcu P; Schaefer J; Erter JW; Furman RR; Shitabata PK; Crowson AN
J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases.
Ng AP; Lade S; Rutherford T; McCormack C; Prince HM; Westerman DA
Haematologica; 2006 Jan; 91(1):143-4. PubMed ID: 16434387
[TBL] [Abstract][Full Text] [Related]
13. Expression of dendritic cell markers CD11c/BDCA-1 and CD123/BDCA-2 in coronary artery disease upon activation in whole blood.
Van Brussel I; Van Vré EA; De Meyer GR; Vrints CJ; Bosmans JM; Bult H
J Immunol Methods; 2010 Oct; 362(1-2):168-75. PubMed ID: 20888334
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.
Ferrari S; Malugani F; Rovati B; Porta C; Riccardi A; Danova M
Oncol Rep; 2005 Jul; 14(1):113-20. PubMed ID: 15944777
[TBL] [Abstract][Full Text] [Related]
15. CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma).
Weaver J; Hsi ED
J Cutan Pathol; 2008 Oct; 35(10):975-7. PubMed ID: 18822062
[No Abstract] [Full Text] [Related]
16. Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies.
Bueno C; Almeida J; Lucio P; Marco J; Garcia R; de Pablos JM; Parreira A; Ramos F; Ruiz-Cabello F; Suarez-Vilela D; San Miguel JF; Orfao A
Haematologica; 2004 Jan; 89(1):58-69. PubMed ID: 14754607
[TBL] [Abstract][Full Text] [Related]
17. CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor).
Shiman M; Marchione R; Ricotti C; Romanelli P; Alonso-Llamazares J
Dermatol Online J; 2008 Nov; 14(11):5. PubMed ID: 19094843
[TBL] [Abstract][Full Text] [Related]
18. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells.
Jacob MC; Chaperot L; Mossuz P; Feuillard J; Valensi F; Leroux D; Béné MC; Bensa JC; Brière F; Plumas J
Haematologica; 2003 Aug; 88(8):941-55. PubMed ID: 12935983
[TBL] [Abstract][Full Text] [Related]
19. CD4+ CD56+ blastic tumor of the skin: cytogenetic observations and further evidence of an origin from plasmocytoid dendritic cells.
Hallermann C; Middel P; Griesinger F; Gunawan B; Bertsch HP; Neumann C
Eur J Dermatol; 2004; 14(5):317-22. PubMed ID: 15358570
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell neoplasms.
Liang X; Graham DK
Cancer; 2008 Apr; 112(7):1425-36. PubMed ID: 18286525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]